Ozette Technologies
Latest round
- Series A
Last raised
- Jul 2022
Total raised
- $32M
Investors
- 8
About Ozette Technologies
Ozette Technologies, Inc.Ozette Technologies, Inc. offers AI-driven solutions designed for cytometry and immune data analysis. The company was co-founded by Ali Ansary, Greg Finak, and Raphael Gottardo. Its headquarters are located in Seattle, US.Ozette Technologies specializes in advanced AI-driven computational analysis solutions tailored for cytometry and immune data analysis. Their cloud-native analysis platform processes spectral and conventional cytometry data efficiently, enabling researchers to derive insights from complex immune data. The platform is utilized by pharmaceutical companies and academic institutions in North America and Europe, focusing on targeted therapies related to patients' immune cells.Ozette Technologies generates revenue through B2B transactions with pharmaceutical and academic organizations via the sale of its AI-driven analysis platform and associated services.In July 2022, Ozette Technologies, Inc.
Who invested in Ozette Technologies
8 investors across 2 rounds
See all investors in Ozette Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ozette Technologies
Who invested in Ozette Technologies?
Ozette Technologies has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ozette Technologies raised?
Ozette Technologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ozette Technologies last raise money?
Ozette Technologies's most recent round on record is a Series A, in Jul 2022.
What does Ozette Technologies do?
Ozette Technologies is a biotechnology company.
Where is Ozette Technologies headquartered?
Ozette Technologies is headquartered in Seattle, US.
Which VCs invest in companies like Ozette Technologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ozette Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Ozette Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.